The population's use of pharmaceuticals

Medical Care

Volumn 37, Issue 6 SUPPL. 1, 1999, Pages

  Metge, Colleen ^a   Black, Charlyn ^b   Peterson, Sandra ^b   Kozyrskyj, Anita L ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Defined daily dose (DDD); Drug utilization; Patterns of care; Pharmaceutical use; POPULIS

Indexed keywords

AGE; ARTICLE; CANADA; COST; DEMOGRAPHY; DRUG COST; DRUG UTILIZATION; ECONOMICS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH SERVICES RESEARCH; HEALTH SURVEY; HUMAN; INFORMATION SYSTEM; NEEDS ASSESSMENT; ORGANIZATION AND MANAGEMENT; PRESCRIPTION; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICS;

AGE FACTORS; COMMUNITY HEALTH PLANNING; COST SHARING; DRUG COSTS; DRUG UTILIZATION; HEALTH EXPENDITURES; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HEALTH STATUS INDICATORS; HUMANS; INFORMATION SYSTEMS; MANITOBA; NEEDS ASSESSMENT; PRESCRIPTIONS, DRUG; RESIDENCE CHARACTERISTICS; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 0033145907     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199906001-00008     Document Type: Article

References (51)

1. Shanahan M, Steinbach C, Burchill C, Friesen D, Black C. Adding up provincial expenditures on health care for Manitobans. Med Care 1999;37(suppl):JS60.
2. Health Canada. National Health Expenditures in Canada, 1975-1994. Ottawa, Ontario: Health Canada, 1996.
3. Melnychuk D, Moride Y, Abenhaim L. Monitoring of drug utilization in public health surveillance activities: a conceptual framework. Can J Public Health 1993;84:45.
4. World Health Organization. The selection of essential drugs. Report of a WHO Committee. Technical Report, Series. No. 615. Geneva, Switzerland, 1977.
5. Tognoni G. Drug use and monitoring. In: Holland WW, ed. Evaluation of health care. London: Oxford University Press, 1983:207.
6. Westerholm B, Agenas I, Dahlstrom M, Nordenstam I. Relation between drug utilization and morbidity patterns. Acta Med Scand 1984;683(suppl):95.
7. Skegg DCG. Relation between drug utilization and morbidity: A record linkage study. Acta Med Scand 1984;683(suppl):81.
8. Bergman U, Elmes P, Halse M, Halvorsen T, Hood H, Lunde PK, et al. The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol 1975;8:83.
9. Griffiths K, McDevitt DG, Andrew M, Baksaas I, Lunde PK, Bergman U, et al. Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol 1985;29:1.
10. Lunde PKM, Baksaas I, Halse M, et al. The methodology of drug utilization studies. Copenhagen: WHO Regional Publications, European Series, 1979;8:17.
11. Serradell J, Bjornson DC, Hartzema AG. Drug utilization study methodologies: national and international perspectives. Drug Intell Clin Pharm 1987; 21:994.
12. Statistics Canada. National Population Health Survey (NPHS), 1994. Ottawa, Ontario: Statistics Canada, 1994.
13. National Center for Health Statistics. National Ambulatory Medicare Care Survey for Drug Mentions, 1993. (Pub. No. NTIS No. PB94-114097INZ). Hyattsville, MD, 1994.
14. National Center for Health Statistics. National Health Interview Survey, 1995. (Pub. No. NTIS No. PB98-104532/40/57INC). Hyattsville, MD, 1998.
15. Leibowitz A, Manning WG, Newhouse JP. The demand for prescription drugs as a function of cost sharing. Soc Sci Med 1985;21:1063.
16. Newhouse JP and The Insurance Experiment Group. Free for all? Lessons from RAND Health Insurance Experiment. Cambridge, MA: Harvard University Press, 1993.
17. Bacovsky RA. Federal, provincial and territorial government-sponsored drug plans and databases. Presented at the Conference on National Approaches to Pharmacare, Saskatoon, Saskatchewan, 1998:18.
18. Health Canada. Canada health action: Building on the legacy. The final report of the National Forum on Health. Ottawa, Ontario: Health Canada, 1997.
19. Sketris IS, Brown M, Murray TJ, Fisk JD, McLean K. Drug therapy in multiple sclerosis: a study of Nova Scotia senior citizens. Clin Therap 1996;18:303.
20. Tamblyn RM, McLeod PJ, Abrahamowicz M, Monette J, Gayton DC, Berkson L, et al. Questionable prescribing for elderly patients in Quebec. Can Med Assoc J 1994;150:1801.
21. Kephart G, Sketris I, Smith M, Maheu A, Brown M. Coprescribing of nonsteroidal antiinflammatory drugs and cytoprotective and antiulcer drugs in Nova Scotia's senior population. Clin Ther 1995;17:1159.
22. Saskatchewan Health. Who uses prescription drugs: Results from a population-wide study in Saskatchewan. Regina, Saskatchewan, 1992.
23. Miller E, Blatman B, Einarson TR. A survey of population-based drug databases in Canada. Can Med Assoc J 1996;154:1855.
24. Gormley M, Barer M, Melia P, Helston D. The growth in use of health services: 1977/78 to 1985/86. Regina, Saskatchewan: Saskatchewan Health, 1990.
25. Quinn K, Baker M, Evans B. Clinical and community studies. A population-wide profile of prescription drug use in Saskatchewan 1989. Can Med Assoc J 1992;146:2177.
26. Metge CJ, Black C, Kozyrskyj A, Roos NP, Peterson S, Bogdanovic B. Pharmaceutical use in Manitoba, 1996: Key findings. Winnipeg, Manitoba: Manitoba Centre for Health Policy and Evaluation, 1998.
27. World Health Organization. World Health Organization's Centre for Drug Statistics Methodology: Guidelines for ATC classification and DDD assignment. Oslo, Norway: World Health Organization, 1995.
28. Kozyrskyj A. Validation of a new prescription database in Manitoba: An opportunity to evaluate pharmacist participation in drug utilization review. MSc Thesis, University of Manitoba, Winnipeg, Manitoba, 1996.
29. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol 1989;129:837.
30. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiologic research: The accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995;48:999.
31. Merlo J, Wessling A, Melander A. Comparisons of dose standard units for drug utilization studies. Eur J Clin Pharmacol 1996;50(1-2):27.
32. Roos NP, Fransoo R, Bogdanovic B, Friesen D, MacWilliam L. Issues in planning for specialist physicians. Med Care 1999;37(suppl):JS229.
33. Carstairs V, Morris R. Deprivation and health in Scotland. Aberdeen, Scotland: Aberdeen University Press, 1991.
34. Eyles J, Birch S, Chambers J, Hurley J, Hutchison B. A needs-based methodology for allocating health care resources in Ontario, Canada: Development and an application. Soc Sci Med 1993;33:489.
35. U.S. General Accounting Office. Public health: A health status indicator for targeting federal aid to states. Washington, D.C.: U.S. General Accounting Office. Pub. No. GAO/HEHS 97-13, 1996.
36. Roos NP, Black C, Roos LL, Frohlich N, DeCoster C, Mustard CA, et al. Managing health services: How the Population Health Information System (POPULIS) works for policymakers. Med Care 1999;37(suppl):JS27.
37. Roos NP, Mustard CA. Variation in health and health care use by socioeconomic status in Winnipeg, Canada: Does the system work well? Yes and no. Milbank Q 1997;75:89.
38. Mustard CA, Roos NP. The relationship of prenatal care and pregnancy complication to birthweight outcome: Results from Winnipeg, Canada. Am J Public Health 1994;84:1450.
39. Wilkins R. Use of postal codes and addresses in the analysis of health data. Health Rep 1993;5:157.
40. Krieger N. Overcoming the absence of socioeconomic data in medical records: Validation and application of census based methodology. Am J Public Health 1992;82:703.
41. Skoll SL, August RL, Johnson GE. Drug prescribing for the elderly in Saskatchewan during 1976. Can Med Assoc J 1979;121:1074.
42. Hale WE, May FE, Marks RG, Stewart RB. Drug use in an ambulatory elderly population: A five year update. Drug Intell Clin Pharm 1987;21:530.
43. Nolan L, O'Malley K. Patients, prescribing, and benzodiazepines. Eur J Clin Pharmacol 1988;35:225.
44. Cooperstock R, Parnell P. Research on psychotropic drug use: A review of findings and methods. Soc Sci Med 1982;16:1179.
45. Power B, Downey W, Schnell BR. Utilization of psychotropic drugs in Saskatchewan: 1970-1980. Can J Psychiatry 1983;28:547.
46. Rawson NSB, D'arcy C. Sedative-hypnotic drug use in Canada. Health Rep 1991;3(1):33.
47. Tataryn DJ, Roos N, Black D. Utilization of physician resources: Vol 1. Key findings. Winnipeg, Manitoba: Manitoba Centre for Health Policy and Evaluation, 1994.
48. Demers M. Factors explaining the increase in cost for physician care in Quebec's elderly population. Can Med Assoc J 1996;155:1555.
49. Black C. Using existing data sets to study aging and the elderly. An introduction. Can J Aging 1995;14:135.
50. Gurland BJ, Cross PS. Epidemiology for psychopathology in old age: some implications for clinical services. Psychiatr Clin North Am 1982;5:11.
51. Roos NP, Black C, Roos LL, Frohlich N, DeCoster C, Mustard CA, et al. Managing health services: How administrative data and population-based analyses can focus the agenda. Health Serv Manage Res 1998;11(3):49.